PreveCeutical Medical Statistics
Total Valuation
CSE:PREV has a market cap or net worth of CAD 22.83 million. The enterprise value is 27.42 million.
Market Cap | 22.83M |
Enterprise Value | 27.42M |
Important Dates
The last earnings date was Tuesday, May 27, 2025.
Earnings Date | May 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:PREV has 570.65 million shares outstanding. The number of shares has increased by 0.19% in one year.
Current Share Class | 570.65M |
Shares Outstanding | 570.65M |
Shares Change (YoY) | +0.19% |
Shares Change (QoQ) | +42.43% |
Owned by Insiders (%) | 18.52% |
Owned by Institutions (%) | n/a |
Float | 464.95M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -3.16 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.10 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -57.89 |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -9.71 |
Interest Coverage | -3.92 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -360.81% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 17.96% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 0.09, so CSE:PREV's price volatility has been lower than the market average.
Beta (5Y) | 0.09 |
52-Week Price Change | +33.33% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 56.67 |
Average Volume (20 Days) | 213,562 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.29M |
Pretax Income | -1.70M |
Net Income | -1.70M |
EBITDA | -1.27M |
EBIT | -1.29M |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 5,475 in cash and 4.60 million in debt, giving a net cash position of -4.59 million or -0.01 per share.
Cash & Cash Equivalents | 5,475 |
Total Debt | 4.60M |
Net Cash | -4.59M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | -7.22M |
Book Value Per Share | -0.01 |
Working Capital | -7.32M |
Cash Flow
In the last 12 months, operating cash flow was -472,634 and capital expenditures -1,020, giving a free cash flow of -473,654.
Operating Cash Flow | -472,634 |
Capital Expenditures | -1,020 |
Free Cash Flow | -473,654 |
FCF Per Share | -0.00 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:PREV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.19% |
Shareholder Yield | n/a |
Earnings Yield | -7.46% |
FCF Yield | -2.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
Last Split Date | May 23, 2018 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |